https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

IDIVAL brings biomedical research closer to Valdecilla’s new residents with a conference aimed at boosting their scientific development

16 de April de 2026

The Valdecilla Health Research Institute (IDIVAL) has organized the conference “Discover research and what IDIVAL offers you” at the Marqués de Valdecilla University Hospital, an initiative aimed at first‑year residents (R1) with the goal of introducing them to the hospital’s research ecosystem and encouraging the integration of scientific activity into their training from the very […]

Read more →

The Valdecilla Biobank shows patient associations how biological samples drive biomedical research

15 de April de 2026

The patient associations participating in the forum “Advancing in Research”, organized by the Marqués de Valdecilla Research Institute (IDIVAL), visited the Valdecilla Biobank to learn first-hand about the operation of this scientific platform, its key role in the development of biomedical projects in Cantabria, and how biological samples are managed to advance the study of […]

Read more →

The Rheumatology Department of Sierrallana leads the first clinical trial to demonstrate the effectiveness of cardiovascular event prevention based on the detection of subclinical atherosclerosis

13 de April de 2026

The Rheumatology Department of Sierrallana Hospital, in collaboration with the Clinical Trials Agency of the Valdecilla Health Research Institute (IDIVAL), has designed and launched a clinical trial aimed at optimizing the primary prevention of cardiovascular (CV) events in patients with inflammatory rheumatic diseases. The study, titled “Randomized clinical trial to assess the efficacy and safety […]

Read more →

IDIVAL strengthens its collaboration with patient associations at the ‘Advancing in Research’ Forum and presents the latest developments of Cohorte Cantabria

9 de April de 2026

The Marqués de Valdecilla Research Institute (IDIVAL) held the forum “Advancing in Research,” a meeting aimed at patient associations that made it possible to share the main biomedical research projects being developed in Cantabria and to strengthen collaboration between scientists, healthcare professionals, and civil society. The event also served to present the progress of Cohorte […]

Read more →

The IDIVAL, commited to the prevention of pneumococcal disease in adults

1 de April de 2026

By 2040, 27% of the Spanish population will be over the age of 65, and life expectancy will have increased by three years compared to 2021. This progressive ageing will not only reshape the demographic structure but also significantly increase the prevalence of chronic diseases. In this context, the Valdecilla Health Research Institute (IDIVAL), firmly […]

Read more →

IDIVAL welcomes the visit of the Catalan Minister for Research and Universities to strengthen scientific cooperation

31 de March de 2026

The Marqués de Valdecilla Research Institute (IDIVAL) received the institutional visit of Núria Montserrat Pulido, Minister for Research and Universities of the Generalitat of Catalonia, as part of her trip to Cantabria to learn first-hand about the scientific activity carried out by various research centres linked to the University of Cantabria. During her visit to […]

Read more →

IDIVAL and UC advance in Lisbon in the development of innovative digital health solutions within the SAM project

30 de March de 2026

Members of the Health Economics Group at the Marqués de Valdecilla Research Institute (IDIVAL) and the University of Cantabria (UC), participants in the European project “Intelligent Digital Twin for Social Prescribing in Primary Healthcare” (SAM, acronym for Health, Social, Assets and Map), aimed at improving healthcare and population well‑being and framed within the Interreg Sudoe […]

Read more →

EUnetCCC designates 14 Spanish comprehensive cancer centres as “EU‑Designated CCC”, including CICCAR, with participation from IDIVAL

25 de March de 2026

The European Network of Comprehensive Cancer Centres (EUnetCCC) has designated the 14 Comprehensive Cancer Centres (CCC) in Spain, marking an important step toward more coordinated, equitable, and accessible cancer care across Europe. The Joint Action has just announced the following centres as EU‑Designated CCCs: CCC Euskadi – Basque Country, Regional University Hospital of Málaga, Virgen […]

Read more →

Health education during hospitalization, key to improving quality of life in patients with chronic respiratory disease

23 de March de 2026

A scientific article co‑authored by David Peña Otero, researcher in the Nursing Group at the Marqués de Valdecilla Research Institute (IDIVAL), has analyzed the effectiveness of educational interventions aimed at hospitalized patients with chronic respiratory diseases. The study is a systematic review that examines the available scientific evidence on this type of intervention and its […]

Read more →

Presentation of the INN-VAL and DTEC-VAL Innovation Support Programs

18 de March de 2026

The INN-VAL and DTEC-VAL calls, aimed at promoting innovation in the healthcare and scientific environment, will soon open their application periods. To present their features and requirements, an online informational meeting will be held on March 25. During the session, the most relevant aspects of both programs will be discussed, including the documentation required to […]

Read more →
Idival
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.